The presence of brain neurofibrillary tau tangles correlates with cognitive decline [8], and plasma measurements of total and phosphorylated tau have emerged as promising biomarkers for the detection and monitoring of AD progression [9–12]. The gene discussed is MAPT; the disease is Alzheimer disease.